STC1 and inflammatory bowel disease: Previous research on patients with inflammatory bowel disease (IBD) has identified several genes (IL13RA2, TNFRSF11B, STC1, IL-6, and IL-11) that constitute potential biomarkers that can identify patients with limited response to IFX, which is consistent with our study (12, 23).